Cerebral Embolic Protection: Is There a Benefit for Left Atrial and Mitral Valve Procedures?

Besir Besir1, Samir R Kapadia2

  • 1Department of Cardiovascular Medicine, Heart, Vascular and Thoracic Institute, Cleveland Clinic, 9500 Euclid Avenue, J2-3, Cleveland, OH, 44195, USA.

PubMed

Insights

Cerebral embolic protection devices (CEPD) show promise in reducing stroke risk during left atrial and mitral valve procedures. Antithrombotic management is crucial for patient safety and mitigating long-term stroke risk.

Area of Science:

  • Cardiovascular Interventions
  • Neurology
  • Medical Device Technology

Background:

  • Stroke is a significant complication of structural heart interventions.
  • Cerebral embolic protection devices (CEPD) were developed to reduce stroke risk, initially for transcatheter aortic valve replacement (TAVR).
  • The efficacy of CEPD in left atrial appendage closure (LAAO) and mitral valve procedures requires further investigation.

Purpose of the Study:

  • To review current evidence on CEPD use in left atrial and transcatheter mitral valve procedures.
  • To summarize antithrombotic management strategies for these interventions.

Main Methods:

  • Literature review of studies on cerebral embolic protection devices.
  • Analysis of antithrombotic strategies in structural heart interventions.
  • Review of periprocedural stroke risk and detection methods like DW-MRI.

Main Results:

  • The risk of periprocedural stroke in left atrial and mitral valve interventions is substantial.
  • Cerebral ischemic injuries are common, with debris often found on CEPD filters.
  • Antithrombotic therapy is vital, tailored to individual bleeding and ischemic risk.

Conclusions:

  • The risk of stroke during left atrial and transcatheter mitral valve procedures is not negligible.
  • Antithrombotic therapy is essential for mitigating periprocedural and long-term stroke risk.
  • Further prospective studies are needed to confirm CEPD efficacy in these procedures.
Abstract

Related Concept Videos

Imaging Studies for Cardiovascular System II:Types of Echocardiography01:20

Imaging Studies for Cardiovascular System II:Types of Echocardiography

Echocardiography plays a role in assessing cardiac health and detecting heart conditions, with various types providing critical insights for diagnosis and treatment.
Types of Echocardiography
Transthoracic Echocardiography (TTE)
TTE is the most common type of echocardiogram which involves placing a transducer on the patient's chest, emitting sound waves to create heart images. TTE is invaluable for evaluating the heart's size, structure, and motion, making it particularly useful for...
234
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
6
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
3
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
3